x.com· @ · X·· 2026-04-22Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
Body
At his poster during #AACR26, Yun Huang, PhD, shares how mitochondrial redox pathways may create a therapeutic vulnerability in KEAP1/NRF2-mutant non-small cell lung cancer. #MoffittAACR26 @AACR https://t.co/H7qIRU2mGU
Heat 14 · 11 likes · 0 replies · 3 reposts
Source: x.com · x.com